Literature DB >> 17159209

Type IV pili and type II secretion play a limited role in Legionella pneumophila biofilm colonization and retention.

Claressa E Lucas1, Ellen Brown, Barry S Fields.   

Abstract

Legionellae colonize biofilms in building water systems, yet little is known about their interaction with the organisms in these microbial communities. The role of Legionella pneumophila type IV pili and the type II secretion pre-pilin peptidase was evaluated in a model biofilm system. L. pneumophila strains 130b (wild-type), BS100 (a type IV pili mutant) and NU243 (a pre-pilin peptidase mutant) were assessed for attachment and retention in an established biofilm. Strains 130b and NU243 colonized the biofilm at a similar level while BS100 attached at a tenfold lower level. Over time, NU243 dropped below the level of detection while BS100 remained in the biofilm throughout the course of the experiment. The wild-type strain decreased but remained at a considerably higher level than either of the mutants. Inclusion of amoebae with BS100 allowed for attachment and retention at a level similar to 130b. NU243, which displays reduced intracellular replication, was able to establish itself and persist in the presence of amoebae. Thus, type IV pili and the pre-pilin peptidase facilitate L. pneumophila colonization of biofilms but are not required in the presence of a host for intracellular replication.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17159209     DOI: 10.1099/mic.0.2006/000497-0

Source DB:  PubMed          Journal:  Microbiology        ISSN: 1350-0872            Impact factor:   2.777


  9 in total

1.  Importance of type II secretion for survival of Legionella pneumophila in tap water and in amoebae at low temperatures.

Authors:  Maria A Söderberg; Jenny Dao; Shawn R Starkenburg; Nicholas P Cianciotto
Journal:  Appl Environ Microbiol       Date:  2008-07-11       Impact factor: 4.792

2.  Virulence factors encoded by Legionella longbeachae identified on the basis of the genome sequence analysis of clinical isolate D-4968.

Authors:  Natalia A Kozak; Meghan Buss; Claressa E Lucas; Michael Frace; Dhwani Govil; Tatiana Travis; Melissa Olsen-Rasmussen; Robert F Benson; Barry S Fields
Journal:  J Bacteriol       Date:  2009-12-11       Impact factor: 3.490

3.  A type II secreted RNase of Legionella pneumophila facilitates optimal intracellular infection of Hartmannella vermiformis.

Authors:  Ombeline Rossier; Jenny Dao; Nicholas P Cianciotto
Journal:  Microbiology (Reading)       Date:  2009-03       Impact factor: 2.777

4.  Virulence properties of the legionella pneumophila cell envelope.

Authors:  Olga Shevchuk; Jens Jäger; Michael Steinert
Journal:  Front Microbiol       Date:  2011-04-25       Impact factor: 5.640

Review 5.  Occurrence and Control of Legionella in Recycled Water Systems.

Authors:  Patrick K Jjemba; William Johnson; Zia Bukhari; Mark W LeChevallier
Journal:  Pathogens       Date:  2015-07-01

6.  Assessing the impact, genomics and evolution of type II secretion across a large, medically important genus: the Legionella type II secretion paradigm.

Authors:  Richard C White; Nicholas P Cianciotto
Journal:  Microb Genom       Date:  2019-06-05

7.  Migration of Acanthamoeba through Legionella biofilms is regulated by the bacterial Lqs-LvbR network, effector proteins and the flagellum.

Authors:  Sarah Michaelis; Sabrina Brülisauer; Ramon Hochstrasser; Thomas Sura; Mingzhen Fan; Sandra Maaß; Dörte Becher; Hubert Hilbi
Journal:  Environ Microbiol       Date:  2022-05-25       Impact factor: 5.476

8.  Legionella pneumophila persists within biofilms formed by Klebsiella pneumoniae, Flavobacterium sp., and Pseudomonas fluorescens under dynamic flow conditions.

Authors:  Catherine R Stewart; Viraj Muthye; Nicholas P Cianciotto
Journal:  PLoS One       Date:  2012-11-21       Impact factor: 3.240

Review 9.  Biofilms: the stronghold of Legionella pneumophila.

Authors:  Mena Abdel-Nour; Carla Duncan; Donald E Low; Cyril Guyard
Journal:  Int J Mol Sci       Date:  2013-10-31       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.